P/S ratio for Corcept Therapeutics
(CORT)
P/S ratio as of January 2025 (TTM): 8.24
According to Corcept Therapeutics
's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.11 . At the end of 2024 the company had a P/S ratio of 7.30 .
P/S ratio history for Corcept Therapeutics
from 2007 to 2024
2008 2012 2016 2020 2024 5000 10000 15000 20000 25000 30000 0 companiesmarketcap.com
PS ratio at the end of each year
Year
P/S ratio
Change
2024 7.30 5.22% 2023 6.94 27.57% 2022 5.44 -12.9% 2021 6.25 -27.27% 2020 8.59 89.9% 2019 4.52 -26.07% 2018 6.12 -52.75% 2017 12.9 30.61% 2016 9.91 -8.71% 2015 10.9 -5.22% 2014 11.5 -62.98% 2013 30.9 -28.3% 2012 43.2 2011 N/A 2010 N/A -100% 2009 > 1000 6549.54% 2008 87.1 -60.46% 2007 220
P/S ratio for similar companies or competitors Company P/S ratio P/S ratio difference diff. Country 3.92 -52.42% ๐บ๐ธ USA 2.42 -70.70% ๐บ๐ธ USA 4.00 -51.52% ๐จ๐ญ Switzerland 17.5 112.66% ๐บ๐ธ USA 2.54 -69.16% ๐บ๐ธ USA 4.00 -51.51% ๐บ๐ธ USA 1.50 -81.83% ๐บ๐ธ USA 6.24 -24.30% ๐บ๐ธ USA 4.60 -44.14% ๐บ๐ธ USA